Cargando…

Expression of long noncoding RNAs in cancer‐associated fibroblasts linked to patient survival in ovarian cancer

Cancer‐associated fibroblasts (CAFs) are the most abundant cell type in the tumor microenvironment and are responsible for producing the desmoplastic reaction that is a poor prognostic factor in ovarian cancer. Long non‐coding RNAs (lncRNAs) have been shown to play important roles in cancer. However...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colvin, Emily K., Howell, Viive M., Mok, Samuel C., Samimi, Goli, Vafaee, Fatemeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226184/ https://www.ncbi.nlm.nih.gov/pubmed/32058624 http://dx.doi.org/10.1111/cas.14350

Ejemplares similares

Functional prediction of long non-coding RNAs in ovarian cancer-associated fibroblasts indicate a potential role in metastasis
por: Vafaee, Fatemeh, et al.
Publicado: (2017)

Why the dual origins of high grade serous ovarian cancer matter
por: Colvin, Emily K., et al.
Publicado: (2020)

Modelling Epithelial Ovarian Cancer in Mice: Classical and Emerging Approaches
por: Zakarya, Razia, et al.
Publicado: (2020)

The Extracellular Matrix in Epithelial Ovarian Cancer – A Piece of a Puzzle
por: Cho, Angela, et al.
Publicado: (2015)

Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer
por: Moran-Jones, Kim, et al.
Publicado: (2015)

Long noncoding RNAs and their link to cancer
por: Grixti, Justine M., et al.
Publicado: (2020)

Noncoding RNAs in the Glycolysis of Ovarian Cancer
por: Zhang, Chunmei, et al.
Publicado: (2022)

Dysregulated Expression of Long Noncoding RNAs in Ovarian Cancer
por: Zhong, Yancheng, et al.
Publicado: (2016)

Etiology and Pathogenesis of Epithelial Ovarian Cancer
por: Mok, Samuel C., et al.
Publicado: (2007)

Editorial: Advances in Epithelial Ovarian Cancer: Model Systems, Microenvironmental Influences, Therapy, and Origins
por: Howell, Viive Maarika, et al.
Publicado: (2015)

Long Noncoding RNAs in the Prediction of Survival of Patients with Digestive Cancers
por: Zhao, Shu, et al.
Publicado: (2023)

Ferroptosis-Related Long Noncoding RNAs as Prognostic Biomarkers for Ovarian Cancer
por: Wang, Kaili, et al.
Publicado: (2022)

Long noncoding RNAs as therapeutic targets to overcome chemoresistance in ovarian cancer
por: Chen, Linjiao, et al.
Publicado: (2022)

The Interplay between Long Noncoding RNAs and Proteins of the Epigenetic Machinery in Ovarian Cancer
por: Calanca, Naiade, et al.
Publicado: (2020)

Altered long noncoding RNAs and survival outcomes in ovarian cancer: A systematic review and meta-analysis (PRISMA Compliant)
por: Ning, Li, et al.
Publicado: (2018)

Expression of Long Noncoding RNAs in Fibroblasts from Mucopolysaccharidosis Patients
por: Cyske, Zuzanna, et al.
Publicado: (2023)

Noncoding RNAs link metabolic reprogramming to immune microenvironment in cancers
por: Zhang, Yiyin, et al.
Publicado: (2021)

Culture Models to Define Key Mediators of Cancer Matrix Remodeling
por: Fuller, Emily Suzanne, et al.
Publicado: (2014)

Long noncoding RNAs and the genetics of cancer
por: Cheetham, S W, et al.
Publicado: (2013)

LONG-NONCODING RNAs in gastroesophageal cancers
por: Fanelli, Giuseppe Nicolò, et al.
Publicado: (2018)

Long Noncoding RNAs as Biomarkers in Cancer
por: Bolha, Luka, et al.
Publicado: (2017)

Long noncoding RNAs: a missing link in osteoporosis
por: Silva, Andreia Machado, et al.
Publicado: (2019)

Noncoding RNAs and cancer
por: Yogev, Ohad, et al.
Publicado: (2011)

Noncoding RNAs and Cancer
por: Naeini, Mozhgan Moslemi, et al.
Publicado: (2009)

Patient-Derived Xenograft Models to Improve Targeted Therapy in Epithelial Ovarian Cancer Treatment
por: Scott, Clare L., et al.
Publicado: (2013)

MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers
por: Barwal, Tushar Singh, et al.
Publicado: (2021)

INC280, an orally available small molecule inhibitor of c-MET, reduces migration and adhesion in ovarian cancer cell models
por: Moran-Jones, Kim, et al.
Publicado: (2015)

Long noncoding RNAs (lncRNAs) in human lymphomas
por: Gholami, Ali, et al.
Publicado: (2021)

Portraying breast cancers with long noncoding RNAs
por: Van Grembergen, Olivier, et al.
Publicado: (2016)

The Many Faces of Long Noncoding RNAs in Cancer
por: Wu, Xue, et al.
Publicado: (2018)

Long noncoding RNAs as regulators of cancer immunity
por: Denaro, Nerina, et al.
Publicado: (2018)

Long noncoding RNAs in head and neck cancer
por: Li, Xiuhua, et al.
Publicado: (2016)

Long noncoding RNAs as promising biomarkers in cancer
por: Beylerli, Ozal, et al.
Publicado: (2022)

An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma
por: Colvin, Emily K., et al.
Publicado: (2022)

Expedition to the missing link: Long noncoding RNAs in cardiovascular diseases
por: Yeh, Chih-Fan, et al.
Publicado: (2020)

Noncoding RNAs in Cancer Medicine
por: Cerchia, Laura, et al.
Publicado: (2006)

Noncoding RNAs link PARP1 to heterochromatin
por: Guetg, Claudio, et al.
Publicado: (2012)

A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer
por: Peng, Yao, et al.
Publicado: (2022)

The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectives
por: Fang, Zengli, et al.
Publicado: (2020)

Methylation of cell-free circulating DNA in the diagnosis of cancer
por: Warton, Kristina, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dg4206rsk2trnf76tnef0eetlu